Lyndra Therapeutics

0 followers


Lyndra Therapeutics is pioneering the first-ever oral, ultra-long-acting, sustained-release therapies, which have the potential to fundamentally change the way people take medicine by enabling patients to take a pill once a week rather than daily.

Industries

Headquarters

Stage

Employees

Links

Org chart

Patricia Hurter
CEO, Board Member

Patricia Hurter

Collapse
Jessica Ballinger
President & COO
Tyler Grant
SVP, EPRD
Rosemary Kanasty
Senior Director, Platform Discovery
Colin Gardner
Co-Founder
Kyle Haraldsen
Chief Technology Officer
Klas Holmlund, CFA
Chief Financial Officer
Lindsay Beaupre
Chief People And Workplace Operations Officer
Marie Jardine-Yeats
Vice President Quality Assurance
Patrick Boen
Vice President Clinical Development
Anna Legedza
Director, Biostatistics
Maureen Chlopik
Vice President